Alzheimer's disease Trials in Santa Rosa, United States
Conditions / Alzheimer's disease / Santa Rosa, United States
Research into Alzheimer's disease spans multiple therapeutic approaches and trial phases.
11 total trials for this combination
Showing top 10 of 11 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT01723826 | A Long-Term Safety Extension of Studies ABE4869g and ABE4955g in Participants With Mild to Moderate Alzheimer's Disease Treated With Crenezumab | COMPLETED | PHASE2 |
| NCT02484547 | 221AD302 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease | TERMINATED | PHASE3 |
| NCT01900665 | Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo | TERMINATED | PHASE3 |
| NCT00838110 | A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease | COMPLETED | PHASE3 |
| NCT01741194 | AC-1204 26-Week Long Term Efficacy Response Trial With Optional Open-label Ext | COMPLETED | PHASE2/PHASE3 |
| NCT01073228 | Safety and Cognitive Function Study of EVP-6124 in Patients With Mild to Moderate Alzheimer's Disease | COMPLETED | PHASE2 |
| NCT02079246 | Long-term Safety and Tolerability of Idalopirdine (Lu AE58054) as Adjunctive Treatment to Donepezil in Patients With Mild-moderate Alzheimer's Disease | COMPLETED | PHASE3 |
| NCT00939783 | An Extension To The B1451027 Protocol To Evaluate The Long Term Safety And Tolerability Of Dimebon In Patients With Alzheimer's Disease | TERMINATED | PHASE3 |
| NCT06653153 | A Study of Remternetug (LY3372993) in Early Alzheimer's Disease (TRAILRUNNER-ALZ 3) | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT02006641 | Idalopirdine in Patients With Mild-moderate Alzheimer's Disease Treated With Donepezil | COMPLETED | PHASE3 |